Trials / Completed
CompletedNCT04253197
Ultrasound Staging in the Placenta Accreta
Efficacy of Ultrasound Staging System in Prediction of Morbidly Adherent Placenta
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Beni-Suef University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The investigators evaluated the efficacy of a staging system introduced by the American Institute of ultrasound in medicine 2015 including sonographic parameters associated with morbidly adherent placenta for antenatal prediction of placental invasion.
Detailed description
Morbidly adherent placenta (MAP) defines a spectrum of conditions, including placenta accreta, increta, and percreta, which are associated with significant maternal and fetal morbidity and mortality. Ultrasound evaluation, with grayscale, is the recommended first-line modality for diagnosing MAP. Grayscale ultrasound features suggestive of placenta accreta include the loss of myometrial interface or retroplacental clear space, reduced myometrial thickness and the presence of intraplacental lacunae. Using a staging system by antenatal ultrasound can predict placental invasion antenatally.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ultrasound | Pregnant women in 3rd trimester with anterior placenta previa and lower cesarean section scar. Ultrasound was done and according to parameters of the morbidly adherent placenta, a staging system was conducted. |
Timeline
- Start date
- 2017-03-14
- Primary completion
- 2019-07-20
- Completion
- 2019-12-25
- First posted
- 2020-02-05
- Last updated
- 2020-02-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04253197. Inclusion in this directory is not an endorsement.